Camptosar and Nephropathy - a phase IV clinical study of FDA data


Nephropathy is found among people who take Camptosar, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Camptosar and have Nephropathy. It is created by eHealthMe based on reports of 6,941 people who have side effects when taking Camptosar from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2022

6,941 people reported to have side effects when taking Camptosar.
Among them, 6 people (0.09%) have Nephropathy.

What is Camptosar?

Camptosar has active ingredients of irinotecan hydrochloride. eHealthMe is studying from 6,970 Camptosar users for its effectiveness, alternative drugs and more.

What is Nephropathy?

Nephropathy (damage to or disease of a kidney) is found to be associated with 1,216 drugs and 691 conditions by eHealthMe.

Number of Camptosar and Nephropathy reports submitted per year:

Could Camptosar cause Nephropathy?

Time on Camptosar when people have Nephropathy *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Nephropathy when taking Camptosar *:

  • female: 83.33 %
  • male: 16.67 %

Age of people who have Nephropathy when taking Camptosar *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 20 %
  • 40-49: 40 %
  • 50-59: 20 %
  • 60+: 20 %

Common drugs people take besides Camptosar *:

  1. Cisplatin: 3 people, 50.00%
  2. Mitomycin: 2 people, 33.33%
  3. Etoposide: 2 people, 33.33%
  4. Carboplatin: 2 people, 33.33%
  5. Minocycline Hydrochloride: 1 person, 16.67%
  6. Leukine: 1 person, 16.67%
  7. Hydrocortisone Sodium Phosphate: 1 person, 16.67%
  8. Granisetron Hydrochloride: 1 person, 16.67%
  9. Furosemide: 1 person, 16.67%
  10. Folic Acid: 1 person, 16.67%

Common side effects people have besides Nephropathy *:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 83.33%
  2. Haemoglobin Decreased: 4 people, 66.67%
  3. Thrombocytopenia (decrease of platelets in blood): 3 people, 50.00%
  4. Blood Creatinine Increased: 2 people, 33.33%
  5. Blood Urea Increased: 2 people, 33.33%
  6. Urine Output Decreased: 1 person, 16.67%
  7. Bacteraemia (presence of bacteria in the blood): 1 person, 16.67%
  8. Cardiac Failure Acute: 1 person, 16.67%
  9. Colonic Stenosis (abnormal narrowing of colon): 1 person, 16.67%
  10. Dehydration (dryness resulting from the removal of water): 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Camptosar and have Nephropathy?

Check whether Nephropathy is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Nephropathy and when was it recovered:

Expand to all the drugs that have ingredients of irinotecan hydrochloride:

Alternative drugs to, pros and cons of Camptosar:

Common Camptosar side effects:

Browse all side effects of Camptosar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Nephropathy treatments and more:

COVID vaccines that are related to Nephropathy:

Common drugs associated with Nephropathy:

All the drugs that are associated with Nephropathy:

Common conditions associated with Nephropathy:

All the conditions that are associated with Nephropathy:

How the study uses the data?

The study uses data from the FDA. It is based on irinotecan hydrochloride (the active ingredients of Camptosar) and Camptosar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: